摘要
本文报道大剂量舒芬太尼患者自控镇痛(PCIA)治疗难治性癌痛合并爆发痛患者1例。本例患者因肝门部胆管癌伴腹腔多发淋巴结转移,具有难治性癌痛和频发爆发痛等顽固性症状,预期生存期较短。经化学药物治疗、靶向治疗等积极的干预措施后,仍无法缓解疼痛和痛苦,遂应用大剂量舒芬太尼给予静脉和硬膜外自控镇痛治疗,使患者的顽固性癌痛和爆发痛获得了有效控制。
One patient with refractory cancer pain and breakthrough cancer pain successfully treated by patient controlled analgesia with high-dose sufentanil was reported.Due to hepatic cholangiocarcinoma and multiple abdominal lymph node metastasis with refractory cancer pain and frequent breakthrough pain,her expected survival time was limited.Active anti-cancer interventions such as chemotherapy and targeted therapy can not relieve her refractory pain and distress.After that,the patient's refractory cancer pain and breakthrouth pain was effectively relieved by intravenous and epidural patient-controlled analgesia with high-dose sufentanil.
作者
佘明金
朱文博
She Mingjin;Zhu Wenbo(Department of Oncology,Anhui Provincial Corps Chinese People's Armed Police Force,Hefei City,Anhui Province 230041,China)
出处
《中华疼痛学杂志》
2021年第5期543-546,共4页
Chinese Journal Of Painology
关键词
难治性癌痛
爆发痛
疼痛治疗
镇痛
患者控制
羟可酮
舒芬太尼
Refractory cancer pain
Break-through pain
Pain treatment
Analgesia,patient-controlled
Oxycodone
Sufentanil
